PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib) - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

   #####  Up next

  ![Season Group Achieves EcoVadis Silver Medal, Ranking Among Top 15% of Companies Assessed Globally](https://i0.wp.com/mmx.prnasia.com/media/MS1968309/20260811222353EDT_image_1.jpg?resize=200%2C110&ssl=1 "Season Group Achieves EcoVadis Silver Medal, Ranking Among Top 15% of Companies Assessed Globally")

 [](https://thailandbusinessnews.net/press-release/season-group-achieves-ecovadis-silver-medal-ranking-among-top-15-of-companies-assessed-globally/)

 ###### [Season Group Achieves EcoVadis Silver Medal, Ranking Among Top 15% of Companies Assessed Globally](https://thailandbusinessnews.net/press-release/season-group-achieves-ecovadis-silver-medal-ranking-among-top-15-of-companies-assessed-globally/)

  Published on 12 August 2026 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

NANJING, China, Aug. 12, 2026 /PRNewswire/ — August 6, the NMPA granted approval to Geneseeq’s PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The approval provides critical support for the precise identification and clinical medication of patients with NTRK fusion‑positive solid tumors.

 [![](https://mmx.prnasia.com/media/MS1968504/20260812081838EDT_image_1.jpg?id=OA2866474&p=medium600)](https://mmx.prnasia.com/media/MS1968504/20260812081838EDT_image_1.jpg?id=OA2866474&p=medium600)

As the original companion diagnostic for Eratrectinib, PanTRKare™ addresses key testing challenges including the pan‑tumor distribution, low incidence and complex fusion patterns of NTRK1/2/3 fusions, enabling accurate detection of NTRK fusion variants across diverse cancer types. Following clinical accuracy validation, bridging study results demonstrated that patients tested positive by PanTRKare™ achieved objective response rates highly consistent with those observed in the drug’s clinical trials, in both treatment‑naïve and pre‑treated populations. This further validates the assay’s stability and consistency for companion diagnostic applications.

Eratrectinib marks Nanjing’s first innovative drug approval this year. Through innovative cyclic structural optimization, it delivers more potent and highly selective inhibition of TRK kinases, overcoming structural limitations and drug‑resistance drawbacks of first‑generation agents at the molecular‑mechanism level. The pivotal VC004‑101 clinical trial has comprehensively verified Eratrectinib’s clinical efficacy and long‑term patient benefits. Study data revealed an overall ORR of 68.5% for Eratrectinib. Among patients with follow‑up exceeding six months, the ORR rose further to 89.7%, representing clinically meaningful improvement superior to first‑generation TRK inhibitors.

In terms of long‑term therapeutic benefit, Eratrectinib exhibited favorable PFS and DOR, with a 2‑year PFS rate of 75.7% and a 2‑year DOR rate of 85.5%. These findings confirm its capacity to deliver durable disease control and sustained remission for patients. It also demonstrates prominent advantages in long‑term survival outcomes by effectively prolonging overall survival; the median OS reached 40.7 months, bringing substantial long‑term survival benefits to patients.

Both Vcare PharmaTech and Geneseeq are enterprises located in the Life Science &amp; Health Industry Office of Nanjing Jiangbei New Area, with a solid long‑term collaborative foundation. Eratrectinib gained marketing approval in June this year, and merely two months later, PanTRKare™ obtained approval for its companion diagnostic use. This completes a key link in the diagnosis‑treatment workflow for NTRK‑fusion solid tumors, creating favorable conditions for post‑launch patient identification, clinical implementation and market adoption, and enabling eligible NTRK‑positive patients to access Eratrectinib targeted therapy at an earlier time point. Such expedited dual approvals fully illustrate the synergistic value brought by the strong partnership between the two parties. It also underscores the industrial ecosystem strengths of Life Science &amp; Health Industry Office of Nanjing Jiangbei New Area in connecting upstream‑downstream industrial chains and empowering collaborative innovation among resident enterprises.

**Commercial Cooperation:** Strategic Development Director: Dr. Peng [peng\_yuran@vcarepharmatech.com](mailto:peng_yuran@vcarepharmatech.com)
BD Director: Liam [xu\_minghua@vcarepharmatech.com](mailto:xu_minghua@vcarepharmatech.com)

[Source link ](http://www.prnasia.com/story/archive/5024860_CN24860_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/leads-biolabs-opamtistomig-pd-l1-4-1bb-bispecific-antibody-nda-accepted-by-nmpa-poised-to-become-worlds-first-approved-4-1bb-targeting-therapy/) ## Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy

  NANJING, China, Aug. 21, 2026 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. ("Leads…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- August 21, 2026

   [](https://thailandbusinessnews.net/press-release/unionpay-international-drives-global-interoperability-via-chinas-cross-border-interconnection-payment-gateway/) ## UnionPay International Drives Global Interoperability via China's Cross-border Interconnection Payment Gateway

  SHANGHAI, Sept. 29, 2025 /PRNewswire/ — On September 16, it was announced…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- September 29, 2025

   [](https://thailandbusinessnews.net/press-release/worlds-first-car-t-therapy-for-solid-tumors-available-in-china-soon-2/) ## World's First CAR-T Therapy for Solid Tumors Available in China Soon

  A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI,…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- April 9, 2026

 ##### Most Read

- [![OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP") [OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP")
- [![Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/green-empowerment-low-carbon-symbiosis-beijing-green-development-forum-2026-grandly-opens-at-beijing-municipal-administrative-center/ "Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center") [Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center](https://thailandbusinessnews.net/press-release/green-empowerment-low-carbon-symbiosis-beijing-green-development-forum-2026-grandly-opens-at-beijing-municipal-administrative-center/ "Green Empowerment, Low-Carbon Symbiosis: Beijing Green Development Forum 2026 Grandly Opens at Beijing Municipal Administrative Center")
- [![China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chinas-green-industries-take-center-stage-at-the-china-asean-expo-as-cooperation-in-energy-power-and-new-energy-vehicles-enters-a-new-phase/ "China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase") [China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase](https://thailandbusinessnews.net/press-release/chinas-green-industries-take-center-stage-at-the-china-asean-expo-as-cooperation-in-energy-power-and-new-energy-vehicles-enters-a-new-phase/ "China's Green Industries Take Center Stage at the China-ASEAN Expo as Cooperation in Energy, Power and New Energy Vehicles Enters a New Phase")
- [![Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/hotel-shop-plus-2027-seamless-synergy-across-design-sustainability-digitalization/ "Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization") [Hotel &amp; Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization](https://thailandbusinessnews.net/press-release/hotel-shop-plus-2027-seamless-synergy-across-design-sustainability-digitalization/ "Hotel & Shop Plus 2027: Seamless Synergy across Design, Sustainability, Digitalization")
- [![Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/golden-week-2026-fuels-extended-breaks-and-new-travel-routes-trip-com-group-reveals-rising-destinations-and-regional-trends/ "Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends") [Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends](https://thailandbusinessnews.net/press-release/golden-week-2026-fuels-extended-breaks-and-new-travel-routes-trip-com-group-reveals-rising-destinations-and-regional-trends/ "Golden Week 2026 Fuels Extended Breaks and New Travel Routes: Trip.com Group Reveals Rising Destinations and Regional Trends")
- [![NYP launches Lumina to help students Go Beyond what they thought possible](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/nyp-launches-lumina-to-help-students-go-beyond-what-they-thought-possible/ "NYP launches Lumina to help students Go Beyond what they thought possible") [NYP launches Lumina to help students Go Beyond what they thought possible](https://thailandbusinessnews.net/press-release/nyp-launches-lumina-to-help-students-go-beyond-what-they-thought-possible/ "NYP launches Lumina to help students Go Beyond what they thought possible")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/gold-oil-or-forex-which-markets-are-attracting-traders-attention-today/) ![Gold, Oil or Forex: Which Markets Are Attracting Traders' Attention Today?](https://i0.wp.com/mmx.prnasia.com/media/MS1990549/20260917021311EDT_image_1.jpg?resize=260%2C140&ssl=1 "Gold, Oil or Forex: Which Markets Are Attracting Traders' Attention Today?")

 ## Gold, Oil or Forex: Which Markets Are Attracting Traders' Attention Today?

  KUALA LUMPUR, Malaysia, Sept. 22, 2026 /PRNewswire/ — Financial markets in 2026…

   [](https://thailandbusinessnews.net/press-release/bdx-breaks-ground-on-640mw-ai-data-center-in-west-java-backed-by-845mva-of-secured-grid-power/) ## BDx Breaks Ground on 640MW AI Data Center in West Java, Backed by 845MVA of Secured Grid Power

  First 120MW building expected to enter service from early 2027, supporting…

   [](https://thailandbusinessnews.net/press-release/hong-kong-shopping-festival-marks-singapore-debut-with-100-brands-and-over-350-products-to-discover/) ## Hong Kong Shopping Festival Marks Singapore Debut with 100 Brands and Over 350 Products to Discover

  SINGAPORE, Sept. 22, 2026 /PRNewswire/ — The Hong Kong Trade Development…

   [](https://thailandbusinessnews.net/press-release/dangote-calls-on-africa-to-keep-its-capital-at-home-as-industrialization-takes-center-stage-at-unstoppable-africa/) ## Dangote Calls on Africa to Keep its Capital at Home as Industrialization Takes Center Stage at Unstoppable Africa

  African business leaders call for a bigger share of the continent’s growth,…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
